Androgenetic alopecia can be challenging to treat due to the wide range of available treatments, most of which are not based on evidence from clinical trials. In addition many of the options do not include androgenetic alopecia among the approved indications according to their summaries of product characteristics. A panel of 34 dermatologists from the Spanish Hair Disorders Society of the Spanish Academy of Dermatology and Venereology (AEDV) used the Delphi method to develop a consensus statement on the management of androgenetic alopecia. Over a 2-round process the experts agreed on 138 (86%) of the 160 proposed items, which were structured into 4 blocks of recommendations: general considerations, pharmacologic treatment, procedures and hair transplant, and special cases. The resulting consensus statement based on expert opinion of the scientific evidence can guide professionals in the routine management of androgenetic alopecia.
Dermatology , Humans , Alopecia/drug therapy , Academies and Institutes , Consensus , Hair
Androgenetic alopecia can be challenging to treat due to the wide range of available treatments, most of which are not based on evidence from clinical trials. In addition many of the options do not include androgenetic alopecia among the approved indications according to their summaries of product characteristics. A panel of 34 dermatologists from the Spanish Trichology Society of the Spanish Academy of Dermatology and Venereology (AEDV) used the Delphi method to develop a consensus statement on the management of androgenetic alopecia. Over a 2-round process the experts agreed on 138 (86%) of the 160 proposed items, which were structured into 4 blocks of recommendations: general considerations, pharmacologic treatment, procedures and hair transplant, and special cases. The resulting consensus statement based on expert opinion of the scientific evidence can guide professionals in the routine management of androgenetic alopecia.
Dermatology , Venereology , Humans , Alopecia/drug therapy , Academies and Institutes , Consensus
Encapsulated fat necrosis is a benign entity that has multiple possible conditions in the differential diagnosis. Because of this, the ultrasound and histological studies become highly relevant. We present a 14-year-old boy with this condition who exhibited numerous nodules that were detected after an intentional weight loss of 20kg. The ultrasound and histopathological examinations were necessary to confirm the diagnosis. Even though there is not a clear traumatic record in all cases, trauma constitutes the main hypothesis for its development, by decreasing the blood supply to the adipose tissue lobules and causing subsequent ischemic necrosis. Similar lesions have been described in the omentum and in the breast after surgical procedures or invasive diagnostic tests. In the ultrasound study, at least three presentation patterns have been described, which might match the three histological states, from early fat tissue degeneration to ultimate necrosis and even calcification. It is important to know the clinical characteristics, the ultrasound patterns, and the histological findings of this condition for an accurate diagnosis.
Fat Necrosis/pathology , Ultrasonography , Adolescent , Diagnosis, Differential , Fat Necrosis/diagnostic imaging , Fat Necrosis/etiology , Humans , Male , Skin/injuries
OBJETIVO: Conocer si la introducción de criterios de derivación en la urgencia dermatológica modifica el número de pacientes y las patologías derivadas desde el servicio de Urgencias generales, así como el perfil del paciente que hace uso de este servicio. MATERIAL Y MÉTODOS: Estudio observacional que incluyó de forma consecutiva a los pacientes vistos en Urgencias de Dermatología del Hospital Príncipe de Asturias en un periodo de 31 días de 2015, de marzo a mayo, y en el mismo periodo en 2016. Como variables se recogieron sexo, edad, tiempo de evolución, día de la semana, pruebas complementarias, procedencia, motivo de consulta, diagnóstico y grupo, así como el cumplimiento de los criterios, el destino y si tenía cita previa. RESULTADOS: En 2015 acudieron 525 pacientes y 371 en 2016 (p < 0,001). Fueron atendidos 896 pacientes en total (14,45 pacientes/día); el 55,7% eran mujeres y el 44,3% varones. Se realizaron 121 diagnósticos diferentes, siendo los más frecuentes: otras dermatitis, toxicodermias y dermatitis atópica. Tan solo 32 enfermedades suponen el 70% de los diagnósticos. El 51,6% no cumplió los criterios de derivación urgente. CONCLUSIONES: La introducción de criterios de derivación ha permitido reducir el volumen de pacientes en un 30% en el año 2016. Otras dermatitis y las toxicodermias fueron los principales diagnósticos en ambos grupos. El perfil del paciente coincide con el descrito en la literatura
OBJECTIVE: To determine if the introduction of some referral criteria in the dermatology emergency department has changed the number of patients referred from the emergency department, as well as the type of diseases, and the profile of the patient who uses this service. MATERIAL AND METHODS: A cross-sectional study was conducted on all consecutive patients attended in the emergency department of the Hospital Príncipe de Asturias during a 31-day period from March 2015 to May 2015 and in the same period in 2016. Variables collected were: gender, age, days from the onset, day of the week, complementary diagnostic tests, referral, reason for consultation, diagnosis and group, whether or not they met the criteria, destination, and whether or not they had a previous appointment. RESULTS: A total of 525 patients were seen in dermatology emergency department in 2015, and 371 in 2016 (P < .001). Of the 896 patients seen 55.7% were women and 44.3% men (14.45 patients per day). A total of 121 diagnoses were made, with the most common being: other dermatitis, drug reactions, and atopic dermatitis. Only 32 pathologies made up 70% of the diagnoses. More than half (51.6%) did not meet the referral criteria. CONCLUSIONS: The introduction of referral criteria has led to a reduction of 30% in the number of patients in 2016. The main diagnoses in both groups were other dermatitis and drug reactions. The profile of the patient is in accordance with the description in the literature
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Young Adult , Adult , Middle Aged , Aged , Aged, 80 and over , Skin Diseases/diagnosis , Cross-Sectional Studies , Referral and Consultation , Hospitals , Emergencies
OBJECTIVE: To determine if the introduction of some referral criteria in the dermatology emergency department has changed the number of patients referred from the emergency department, as well as the type of diseases, and the profile of the patient who uses this service. MATERIAL AND METHODS: A cross-sectional study was conducted on all consecutive patients attended in the emergency department of the Hospital Príncipe de Asturias during a 31-day period from March 2015 to May 2015 and in the same period in 2016. Variables collected were: gender, age, days from the onset, day of the week, complementary diagnostic tests, referral, reason for consultation, diagnosis and group, whether or not they met the criteria, destination, and whether or not they had a previous appointment. RESULTS: A total of 525 patients were seen in dermatology emergency department in 2015, and 371 in 2016 (P<.001). Of the 896 patients seen 55.7% were women and 44.3% men (14.45 patients per day). A total of 121 diagnoses were made, with the most common being: other dermatitis, drug reactions, and atopic dermatitis. Only 32 pathologies made up 70% of the diagnoses. More than half (51.6%) did not meet the referral criteria. CONCLUSIONS: The introduction of referral criteria has led to a reduction of 30% in the number of patients in 2016. The main diagnoses in both groups were other dermatitis and drug reactions. The profile of the patient is in accordance with the description in the literature.
Skin Diseases/diagnosis , Adolescent , Adult , Aged , Child , Cross-Sectional Studies , Emergencies , Female , Hospitals , Humans , Male , Middle Aged , Referral and Consultation , Young Adult
No disponible
Humans , Male , Adult , Aged , Hidradenitis Suppurativa/diagnostic imaging , Perianal Glands/diagnostic imaging , Perianal Glands/pathology , Fistula/diagnostic imaging , Dermis/diagnostic imaging , Hidradenitis Suppurativa/complications , Hidradenitis Suppurativa/pathology , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy , Perianal Glands/surgery , Dermis/surgery
No disponible
Humans , Male , Infant , Hyperkeratosis, Epidermolytic/diagnosis , Hyperkeratosis, Epidermolytic/drug therapy , Permethrin/administration & dosage , Erythema/diagnosis , Scabies/diagnosis , Scalp/pathology , Keratoderma, Palmoplantar/diagnosis , Electron Microscope Tomography , Leukocytosis/blood
La alopecia areata constituye un reto terapéutico, sobre todo en sus formas extensas. Antes de iniciar cualquier tratamiento es necesario tener en cuenta algunas consideraciones. Se trata de una enfermedad que no afecta de forma directa a la salud del paciente y que puede presentar resolución espontánea. Las formas extensas, las que se inician en la infancia y las de larga evolución son muy rebeldes a los tratamientos y asocian recaídas. Todos los tratamientos tienen efectos secundarios. Ningún tratamiento ha demostrado alterar el curso de la enfermedad, muy pocos han demostrado eficacia en ensayos clínicos aleatorizados y no existen guías terapéuticas salvo la publicada en 2003 y actualizada en 2012 en el British Journal of Dermatology. Por todo ello, es necesario elaborar un plan de tratamiento individualizado en cada paciente. Se debe comenzar con los fármacos más seguros e inocuos, y pasar al siguiente escalón terapéutico cuando el actual haya demostrado su ineficacia durante un periodo de 6 meses. Se revisan las principales propuestas farmacológicas para alopecia areata, aportando datos sobre su mecanismo de acción, efectos secundarios y posicionamiento terapéutico en función de los estudios disponibles. Finalmente, se propone un algoritmo terapéutico como guía en el manejo de esta patología.
Adrenal Cortex Hormones/therapeutic use , Alopecia Areata/drug therapy , Biological Products/therapeutic use , Immunologic Factors/therapeutic use , Adrenal Cortex Hormones/administration & dosage , Alopecia Areata/therapy , Humans , Janus Kinases/antagonists & inhibitors , Laser Therapy , Minoxidil/therapeutic use , Phototherapy , Platelet-Rich Plasma , Prostaglandins/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Vasodilator Agents/therapeutic use
No disponible
Humans , Male , Adult , Lymphangitis/diagnosis , Penile Diseases/diagnosis , Penile Induration/diagnosis , Penis/pathology , Remission, Spontaneous
